Announcement of transaction price of 36 drugs including Shangyao, hausen and AstraZeneca

▍ 36 drugs, transaction price updated! On January 21, Jiangxi anticancer medicine purchase service center issued the document notice on the result of negotiation of 2018 provincial special centralized purchase price of anticancer medicine in Jiangxi Province According to the document, according to the implementation plan for provincial special centralized procurement of anticancer drugs in Jiangxi Province in 2018 (hereinafter referred to as the plan), Jiangxi Province organized and carried out some price negotiations on anticancer drugs after the study and decision of the leading group meeting on drug bidding and procurement, and now the results of the negotiations are publicized According to the list, the results of the price negotiation involve 36 drugs, 28 pharmaceutical companies, Shangyao, Cr, Novartis, hausen, AstraZeneca The publicity time is from January 21 to January 25, 2019 If there is any objection during the publicity period, please submit the written materials with the official seal of the company to the provincial pharmaceutical purchasing service center before 17:00 on January 25 According to the plan released in September 2018, the anti-cancer drugs incorporated into Jiangxi serious illness medical insurance through competitive negotiation by Jiangxi Medical insurance management department shall be purchased online according to the negotiation results if the enterprise applies and the negotiation price is not higher than the latest national bidding price ▍ purchase of anticancer drugs, two batches of prices have been announced before On January 11, Jiangxi pharmaceutical procurement service platform issued the notice on further improving the procurement of anticancer drugs, which shows that Jiangxi Province will strictly implement the procurement time The results of 2018 provincial special centralized procurement of anticancer drugs in Jiangxi Province have been published and implemented in batches since December 13, 2018, and the use of unsuccessful products will be stopped on December 30. At the same time, all hospitals should strictly implement the bid winning price of drugs, and give priority to purchasing basic drugs and drugs that pass the quality and efficacy evaluation of generic drugs Previously, the leading agency of drug bidding and purchasing in Jiangxi Province has announced the prices of anticancer drugs twice, and now the results and list of the price consultation are published Negotiation results of provincial special centralized purchase price of anticancer drugs in Jiangxi Province in 2018